Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Velcade. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel solid-phase method for Bortezomib (CN104211758B) offers high purity and simplified purification, ensuring reliable supply chain for proteasome inhibitors.
Patent CN103897028A details a heavy-metal-free synthesis of Bortezomib, offering high purity and cost reduction for pharmaceutical manufacturing supply chains.
Novel 8-step route for Bortezomib using isobutylboronic acid, eliminating column chromatography for cost-effective manufacturing.